These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34992498)

  • 1. The lncRNA H19/miR-766-3p/S1PR3 Axis Contributes to the Hyperproliferation of Keratinocytes and Skin Inflammation in Psoriasis via the AKT/mTOR Pathway.
    He Y; Yin X; Yan J; Li X; Sun Q
    Mediators Inflamm; 2021; 2021():9991175. PubMed ID: 34992498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice.
    Tang ZL; Zhang K; Lv SC; Xu GW; Zhang JF; Jia HY
    Cytokine; 2021 Dec; 148():155657. PubMed ID: 34425525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.
    Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B
    Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIR181A2HG inhibits keratinocytes proliferation through miR-223-3p/SOX6 axis.
    Li M; Niu M; Fan X; Chen F; Cao H; Liu Q; Gan S; Yue P; Gao J
    Aging (Albany NY); 2024 Jun; 16(11):9846-9858. PubMed ID: 38848163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the long non-coding RNA, SPRR2C, based on an in vitro psoriatic keratinocyte cell model.
    Yin X; Yang Z; Zhu M; Chen C; Sun Q
    Eur J Dermatol; 2022 Apr; 32(2):171-180. PubMed ID: 35866915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated lncRNA-MSX2P1 promotes the growth of IL-22-stimulated keratinocytes by inhibiting miR-6731-5p and activating S100A7.
    Qiao M; Li R; Zhao X; Yan J; Sun Q
    Exp Cell Res; 2018 Feb; 363(2):243-254. PubMed ID: 29339075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-124-3p Delivered Using Exosomes Attenuates the Keratinocyte Response to IL-17A Stimulation in Psoriasis.
    Liu S; Gong J
    Oxid Med Cell Longev; 2022; 2022():6264474. PubMed ID: 36275890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT-1 regulates the growth of interleukin-22-stimulated keratinocytes via the miR-330-5p/S100A7 axis.
    Zhou Y; Li X; Duan Y; Luo Y; Tang S; Wang J
    Autoimmunity; 2022 Feb; 55(1):32-42. PubMed ID: 34761722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of circ_0024028 inhibits IL-22-induced keratinocyte proliferation and migration by miR-486-3p/AKT3 axis.
    Zhang B; Wu S
    Arch Dermatol Res; 2023 Sep; 315(7):2079-2090. PubMed ID: 36943433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 11. CircRAB3B suppresses proliferation, motility, cell cycle progression and promotes the apoptosis of IL-22-induced keratinocytes depending on the regulation of miR-1228-3p/PTEN axis in psoriasis.
    Lu J; Xu X; Li Y; Yu N; Ding Y; Shi Y
    Autoimmunity; 2021 Aug; 54(5):303-312. PubMed ID: 34096408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17-3p is upregulated in psoriasis and regulates keratinocyte hyperproliferation and pro-inflammatory cytokine secretion by targeting CTR9.
    Li Q; Zhang J; Liu S; Zhang F; Zhuang J; Chen Y
    Eur J Histochem; 2022 Jan; 66(1):. PubMed ID: 35016493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-20a-3p regulates TGF-β1/Survivin pathway to affect keratinocytes proliferation and apoptosis by targeting SFMBT1 in vitro.
    Li R; Qiao M; Zhao X; Yan J; Wang X; Sun Q
    Cell Signal; 2018 Sep; 49():95-104. PubMed ID: 29886071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.
    Huang C; Zhong W; Ren X; Huang X; Li Z; Chen C; Jiang B; Chen Z; Jian X; Yang L; Liu X; Huang H; Shen C; Chen X; Dou X; Yu B
    Cell Death Dis; 2021 Oct; 12(11):963. PubMed ID: 34667159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.
    Gu E; Pan W; Chen K; Zheng Z; Chen G; Cai P
    J Mol Neurosci; 2021 Jun; 71(6):1256-1265. PubMed ID: 33205379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.
    Zhao X; Li R; Qiao M; Yan J; Sun Q
    Inflammation; 2018 Mar; 41(2):496-504. PubMed ID: 29181737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TSIX aggravates spinal cord injury by regulating the PI3K/AKT pathway via the miR-532-3p/DDOST axis.
    Dong J; Wei Z; Zhu Z
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23384. PubMed ID: 37155292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway.
    Wang R; Wang FF; Cao HW; Yang JY
    Life Sci; 2019 Aug; 230():28-34. PubMed ID: 31108094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA XIST Engages in Psoriasis via Sponging miR-338-5p to Regulate Keratinocyte Proliferation and Inflammation.
    Wang Y; Jiang F; Chen F; Zhang D; Wang J
    Skin Pharmacol Physiol; 2022; 35(4):196-205. PubMed ID: 35231918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.